This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
2Find
3Review
4Get in touch
More info
You can access this
clinical trial
if you have
Healthy Male Volunteers
and you are
between 20 and 44
years old
1
This is an early phase trial to determine
the dosage and safety of the new treatment.
Show me locations

The purpose

To evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of a single ascending dose (SAD) administration of E6011 in Japanese healthy volunteers.

Provided treatments

  • Drug: E6011
  • Drug: E6011 Matching Placebo
Tris trial is registered with FDA with number: NCT01731275. The sponsor of the trial is Eisai Co., Ltd. and it is looking for 64 volunteers for the current phase.
Official trial title:
A Phase 1 Single Dose Study of E6011 in Japanese Healthy Adult Male Subjects